Pharmacologic management of pain: The surgeon's responsibility

Surgical Oncology Clinics of North America

Volumn 10, Issue 1, 2001, Pages 71-87

  Ray, J B ^a  

^a HAMOT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIA; ANESTHESIA; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PHYSICIAN ATTITUDE; QUALITY OF LIFE; RESPONSIBILITY; REVIEW; SURGEON; TREATMENT OUTCOME;

EID: 0035138097     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30086-3     Document Type: Review

References (70)

1. Statement on principles guiding care at the end of life
2. Management of pain in elderly patients with cancer
3. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain
4. The under-treatment of pain in ambulatory AIDS patients
5. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer
6. Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study
7. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: A retrospective review
8. The incidence of narcotic induced emesis
9. The management of cancer pain
10. Opioid analgesics: Comparative features and prescribing guidelines
11. Morphine metabolites
12. Cancer pain management
13. Pain and its treatment in outpatients with metastatic cancer
14. Decision near the end of life
15. Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life
16. Common symptoms in patients with advanced cancer
17. Pain and suffering in seriously ill hospitalized patients
18. Impact of environmental and genetic factors on codeine analgesia
19. Opioid rotation for toxicity reduction in terminal cancer patients
20. Direct conversion from oral morphine to transdermal fentanyl: A multicenter study in patients with cancer pain
21. Meperidine-induced delirium
22. Individual variability in the response to different opioids: Report of five cases
23. Unrecognized constipation in patients with advanced cancer: A recipe for therapeutic disaster
24. Dose-ranging study of oxycodone for chronic pain in advanced cancer
25. A dosing nomogram for continuous infusion intravenous naloxone
26. Prevalence and pattern of symptoms in patients with cancer pain: A prospective evaluation of 1635 cancer patients referred to a pain clinic
27. NCCN practice guidelines for cancer pain
28. Chronic nausea and morphine-6-glucuronide
29. Meperidine-related seizures associated with patient-controlled analgesia pumps
30. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene
31. Pain assessment and management standards 1999
32. Central nervous system excitatory effects of meperidine in cancer patients
33. Pain in chronic multiple sclerosis
34. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes
35. Pharmacologic treatment of cancer pain
36. Hyperalgesia medicated by spinal glutamate and substance P receptors blocked by spinal cyclooxygenase inhibition
37. Inappropriate use of naloxone in cancer patients with pain
38. Efficacy of desipramine in painful diabetic neuropathy: A placebo-controlled trial
39. Dextropropoxyphene in postoperative pain
40. A systematic review of antidepressants in neuropathic pain
41. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain
42. The quality of care and symptom control - The effects on the terminal phase of ALS/MND
43. The pharmacokinetics of morphine and morphine glucuronides in kidney failure
44. Intravenous morphine for early pain relief in patients with acute abdominal pain
45. Guidelines for the clinical use transdermal fentanyl
46. Management of pain during débridement: A survey of US burn units
47. NSAIDs and the elderly: Toxicity and economic implications
48. Central analgesic effect of acetaminophen but not of aspirin
49. Pharmacologic management of cancer pain
50. Transdermal fentanyl for cancer pain: Repeated dose pharmacokinetics
51. A review of oxycodone's clinical pharmacokinetics and pharmacodynamics
52. Gabepentin for the treatment of postherpetic neuralgia
53. Non-NSAID pharmacologic treatment options for the management of chronic pain
54. A long-term survey of morphine in cancer pain patients
55. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
56. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: A randomized trial
57. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer
58. A controlled trial to improve care for seriously ill hospitalized patients
59. Pain and analgesics
60. Anti-inflammatory drugs and their mechanism of action
61. Physician attitudes and practice in cancer pain management
62. Pharmacological management of cancer pain
63. Association of acetaminophen hepatotoxicty with fasting and ethanol use
64. Symptoms and suffering at the end of life in children with cancer
65. Validation of World Health Organization guidelines for cancer pain relief: A 10-year prospective study